Trophoblastic Disease During the Third Trimester of
Pregnancy: Ultrasonic Diagnostic, Clinical Case and
Perinatal Outcomes

Vitaly Tskhay; Geyman A; Grebennikova E; Molgacheva E; Strelskaya O

Case Report

Trophoblastic Disease During the Third Trimester of Pregnancy: Ultrasonic Diagnostic, Clinical Case and Perinatal Outcomes

Vitaly Tskhay*, Geyman A, Grebennikova E, Molgacheva E and Strelskaya O

Department of Perinatology, Krasnoyarsk State Medical University, Russia

Corresponding Author

Received Date: December 07, 2018; Published Date: December 13, 2018

Abstract

Trophoblastic disease (TFD) considers rare tumors arising preferentially in reproductive age women. TFD is a relatively rare pathology and occurs at a rate of 1 in 22000 to 1 in 100000 pregnancies [1-3]. Trophoblastic tumors are always associated with pregnancy and can manifest both during pregnancy and after its completion (from several days to several years). The concept of “trophoblastic disease” unites several interconnected various forms of pathological condition of trophoblast: a hydatidiform mole, an invasive mole, choriocarcinoma, a placental bed tumor and an epithelioid trophoblastic tumor [2].

Article Details

Citation

Vitaly Tskhay, Geyman A, Grebennikova E, Molgacheva E, Strelskaya O. Trophoblastic Disease During the Third Trimester of Pregnancy: Ultrasonic Diagnostic, Clinical Case and Perinatal Outcomes. W J Gynecol Women’s Health. 1(4): 2018. WJGWH.MS.ID.000517.